Remodulin Connective Tissue Disease Equipment & Supplies
1 equipment items found
Manufactured by:United Therapeutics Corporation based inSilver Spring, MARYLAND (USA)
Studies establishing effectiveness included patients with NYHA Functional Class II-IV symptoms and etiologies of idiopathic or heritable PAH (58%), PAH associated with congenital systemic-to-pulmonary shunts (23%), or PAH associated with connective tissue diseases (19%). In patients with PAH requiring transition from epoprostenol, Remodulin is ...